Zhi Tong Cai Jing·2025-11-28 08:55Core Viewpoint - The announcement highlights the sale of receivables by Guangzhou Pharmaceutical to Xingzheng Asset Management, which is part of an asset securitization strategy aimed at enhancing liquidity and optimizing asset utilization [1] Group 1: Transaction Details - Guangzhou Pharmaceutical confirmed the sale of receivables with a book value of RMB 442 million to Xingzheng Asset Management, receiving a purchase price of RMB 440 million [1] - This transaction is part of the fourth phase of a foundational asset sale agreement, indicating a structured approach to asset management [1] Group 2: Strategic Implications - The transaction allows Guangzhou Pharmaceutical to convert receivables into cash, thereby improving liquidity and enabling better asset management [1] - The board of directors considers the terms of the transaction to be fair and reasonable, aligning with the overall interests of the company and its shareholders [1]